The OAC is excited to have Currax Pharmaceuticals join the OAC Chairman’s Council at the Silver level. Currax Pharmaceuticals is a specialty biopharmaceutical company focused on enhancing the lives of patients by expanding access to life-changing medications that treat diseases such as obesity. The Currax portfolio includes CONTRAVE® (naltrexone HCl/bupropion HCl), the number one prescribed oral weight-loss brand medication in the US. For more information on Currax Pharmaceuticals, please visit


About OAC’s Chairman’s Council

The Chairman’s Council is OAC’s corporate level of membership and invites companies and individuals to join this prestigious group and show their public support of the OAC and patients. OAC’s Chairman’s Council is an integral way to give back to our cause and plays a key role in making the world a better place for people with obesity. To learn more about OAC’s Chairman’s Council, please click here.